ash highlights: results of the triangle study in mcl
Published 1 year ago • 177 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:44
triangle: ibrutinib with soc or as a substitute to autologous transplantation in first-line mcl
-
7:56
triangle: ibrutinib with standard treatment or without autohsct in younger patients with mcl
-
0:41
ash 2021 highlights in cml
-
1:07
mcl trials to watch out for at ash 2019
-
2:53
mcl: what to look forward to at ash 2020
-
2:31
a patient’s perspective on chronic myeloid leukemia (cml)
-
13:17
mantle cell lymphoma: latest treatments | dr. david miklos, stanford | the patient story
-
11:58
hodgkin lymphoma | hodgkin’s lymphoma | hodgkin’s disease | reed-sternberg cell | pathology
-
2:03
the mcl complete project: nationwide data collection
-
4:34
pv highlights at ash 2020
-
1:28
top picks in all from ash 2020
-
1:00
ash 2022 lba: results from final analysis of alpine - zanubrutinib vs ibrutinib for r/r cll/sll
-
8:54
the hemonc pulse live at ash: tycel phillips, md, on the triangle study, frontline therapy in mcl
-
1:02
recent updates in mcl
-
8:57
outcomes of sct in t-all and t-lbl
-
1:53
cll highlights from ash 2023: the flair study
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks
-
10:25
key highlights in nhl: updates in mcl, the role of transplantation, and novel bispecific antibodies
-
1:23
ash 2014: recent advances in the management of mantle cell lymphoma (mcl)
-
0:42
what to look forward to in lymphoma at ash 2022
-
1:33
lymphoma: highlights at ash 2020
-
4:51
hot updates in r/r mcl at ash 2022: data on pirtobrutinib, glofitamab & zilovertamab